[go: up one dir, main page]

MX2022013805A - Formulaciones de moduladores del receptor glucocorticoide de pirimidin ciclohexilo. - Google Patents

Formulaciones de moduladores del receptor glucocorticoide de pirimidin ciclohexilo.

Info

Publication number
MX2022013805A
MX2022013805A MX2022013805A MX2022013805A MX2022013805A MX 2022013805 A MX2022013805 A MX 2022013805A MX 2022013805 A MX2022013805 A MX 2022013805A MX 2022013805 A MX2022013805 A MX 2022013805A MX 2022013805 A MX2022013805 A MX 2022013805A
Authority
MX
Mexico
Prior art keywords
formulations
receptor modulators
glucocorticoid receptor
pyrimidine
cyclohexyl
Prior art date
Application number
MX2022013805A
Other languages
English (en)
Inventor
Yip- Fong Chia
Stephen Arboleda
Yan Alsmeyer
Gordon Davis
Tyler Clikeman
Original Assignee
Corcept Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Corcept Therapeutics Inc filed Critical Corcept Therapeutics Inc
Publication of MX2022013805A publication Critical patent/MX2022013805A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/513—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52—Two oxygen atoms
    • C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Child & Adolescent Psychology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

La presente invención se relaciona con formulaciones de (E)-6-(4-fenilciclohexil)-5-(3-trifluorometilbencil)-1H-pirimidin -2,4-diona, y con métodos para la elaboración y uso de las mismas.
MX2022013805A 2020-05-06 2021-05-05 Formulaciones de moduladores del receptor glucocorticoide de pirimidin ciclohexilo. MX2022013805A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202063020919P 2020-05-06 2020-05-06
PCT/US2021/030923 WO2021226258A1 (en) 2020-05-06 2021-05-05 Formulations of pyrimidine cyclohexyl glucocorticoid receptor modulators

Publications (1)

Publication Number Publication Date
MX2022013805A true MX2022013805A (es) 2022-11-30

Family

ID=78468351

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2022013805A MX2022013805A (es) 2020-05-06 2021-05-05 Formulaciones de moduladores del receptor glucocorticoide de pirimidin ciclohexilo.

Country Status (14)

Country Link
US (2) US12144812B2 (es)
EP (1) EP4146173A4 (es)
JP (1) JP7474869B2 (es)
KR (1) KR20230006578A (es)
CN (1) CN115515569A (es)
AU (1) AU2021266739B2 (es)
BR (1) BR112022022473A2 (es)
CA (1) CA3182154A1 (es)
CO (1) CO2022017228A2 (es)
IL (1) IL297840A (es)
MX (1) MX2022013805A (es)
PH (1) PH12022553008A1 (es)
TW (1) TWI783474B (es)
WO (1) WO2021226258A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG11202011948SA (en) 2018-06-04 2020-12-30 Corcept Therapeutics Inc Pyrimidine cyclohexenyl glucocorticoid receptor modulators
EP3836920B1 (en) 2018-08-17 2025-10-01 Eidos Therapeutics, Inc. Formulations of ag10
JP2023524780A (ja) 2020-05-06 2023-06-13 コーセプト セラピューティクス， インコーポレイテッド ピリミジンシクロヘキシルグルココルチコイド受容体モジュレーターの多形
US11827608B2 (en) 2020-12-21 2023-11-28 Corcept Therapeutics Incorporated Method of preparing pyrimidine cyclohexyl glucocorticoid receptor modulators

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3011809A1 (de) 1980-03-27 1981-10-01 Cassella Ag, 6000 Frankfurt Pyrimidyl-chinazoline, verfahren zu ihrer herstellung, sie enthaltende pharmazeutische praeparate und ihre verwendung
US5008267A (en) 1988-10-29 1991-04-16 Mitsui Toatsu Chemicals, Incorporated Pyrimidinedione compounds, method of producing the same and antiarrythmic agents containing the same
JPH06128238A (ja) 1992-10-20 1994-05-10 Mitsui Toatsu Chem Inc 新規ピリミジンジオン誘導体
EP0722732A1 (en) 1995-01-24 1996-07-24 Mitsui Toatsu Chemicals, Inc. Long-acting drug formulation containing pyrimidinedione derivatives
JPH1017555A (ja) 1996-07-02 1998-01-20 Mitsui Petrochem Ind Ltd ６−アミノ−５−メチルウラシル誘導体
JP3613382B2 (ja) 1999-03-29 2005-01-26 日下部電機株式会社 金属管の成形ロールスタンド
EP1201660B1 (en) 2000-10-30 2005-08-31 Pfizer Products Inc. Glucocorticoid receptor modulators
GB0029100D0 (en) 2000-11-29 2001-01-10 Karobio Ab Compounds active at the glucocorticoid receptor
MXPA04000692A (es) 2001-07-23 2004-04-21 Corcept Therapeutics Inc MeTODOS PARA EVITAR GANANCIA DE PESO INDUCIDA ANTISICOTICA.
WO2003084937A2 (en) 2002-04-10 2003-10-16 Orchid Chemicals & Pharmaceuticals Limited Pyrimidinedione derivatives useful for the treatment of inflammation and immunological diseases
US7135575B2 (en) 2003-03-03 2006-11-14 Array Biopharma, Inc. P38 inhibitors and methods of use thereof
WO2005105036A1 (en) 2004-04-28 2005-11-10 Natco Pharma Limited Controlled release mucoadhesive matrix formulation containing tolterodine and a process for its preparation
PT1778236E (pt) 2004-07-02 2010-10-19 Corcept Therapeutics Inc Moduladores do receptor de glucocorticóide de pirimidina modificada
US20070155707A1 (en) * 2005-12-29 2007-07-05 Kadmus Pharmaceuticals, Inc. Ionizable inhibitors of fatty acid amide hydrolase
JP5096058B2 (ja) 2007-07-23 2012-12-12 京セラ株式会社 無線基地局及び無線通信方法
ITMI20080947A1 (it) 2008-05-22 2009-11-23 Danieli Off Mecc Gabbia di laminazione e relativo laminatoio per la laminazione longitudinale di corpi astiformi
EP3607942B1 (en) 2008-11-07 2025-10-01 University of Sheffield Medicament and method of diagnosis
US9901551B2 (en) * 2009-04-20 2018-02-27 Ambra Bioscience Llc Chemosensory receptor ligand-based therapies
IT1399629B1 (it) 2010-04-20 2013-04-26 Sms Innse Spa Laminatoio per manufatti allungati.
SG193509A1 (en) 2011-03-18 2013-10-30 Corcept Therapeutics Inc Pyrimidine cyclohexyl glucocorticoid receptor modulators
CN103620675B (zh) 2011-04-21 2015-12-23 三星电子株式会社 对线性预测编码系数进行量化的设备、声音编码设备、对线性预测编码系数进行反量化的设备、声音解码设备及其电子装置
US9622979B2 (en) * 2011-06-29 2017-04-18 Sun Pharmaceutical Industries Limited Multilayered dosage form
PH12017500710B1 (en) * 2014-10-15 2024-01-17 Corcept Therapeutics Inc Fatty liver disease treatment using glucocorticoid and mineralocorticoid receptor antagonists
JP7670462B2 (ja) 2017-06-20 2025-04-30 コーセプト セラピューティクス， インコーポレイテッド 選択的グルココルチコイドレセプターモジュレーターを使用して神経上皮腫瘍を処置する方法
CN112118830B (zh) 2018-05-14 2023-11-10 比利时胶囊公司 高活性剂载量的固体剂型
SG11202011948SA (en) 2018-06-04 2020-12-30 Corcept Therapeutics Inc Pyrimidine cyclohexenyl glucocorticoid receptor modulators
TW202015699A (zh) * 2018-06-05 2020-05-01 瑞典商艾爾比瑞歐公司 苯并噻(二)氮呯(benzothia(di)azepine)化合物及其作為膽汁酸調節劑之用途
AU2020239920A1 (en) 2019-03-18 2021-11-04 Arnold L. Newman Method of improving insulin sensitivity
JP2023524780A (ja) 2020-05-06 2023-06-13 コーセプト セラピューティクス， インコーポレイテッド ピリミジンシクロヘキシルグルココルチコイド受容体モジュレーターの多形
US11827608B2 (en) 2020-12-21 2023-11-28 Corcept Therapeutics Incorporated Method of preparing pyrimidine cyclohexyl glucocorticoid receptor modulators

Also Published As

Publication number Publication date
AU2021266739B2 (en) 2024-11-28
CO2022017228A2 (es) 2023-02-27
CN115515569A (zh) 2022-12-23
TWI783474B (zh) 2022-11-11
JP2023524998A (ja) 2023-06-14
BR112022022473A2 (pt) 2022-12-13
US20250144098A1 (en) 2025-05-08
CA3182154A1 (en) 2021-11-11
IL297840A (en) 2023-01-01
EP4146173A1 (en) 2023-03-15
EP4146173A4 (en) 2024-05-29
US12144812B2 (en) 2024-11-19
JP7474869B2 (ja) 2024-04-25
TW202203926A (zh) 2022-02-01
US20210361651A1 (en) 2021-11-25
KR20230006578A (ko) 2023-01-10
PH12022553008A1 (en) 2024-03-04
AU2021266739A1 (en) 2023-01-05
WO2021226258A1 (en) 2021-11-11

Similar Documents

Publication Publication Date Title
MX2022013805A (es) Formulaciones de moduladores del receptor glucocorticoide de pirimidin ciclohexilo.
MX2022013804A (es) Polimorfos de moduladores de los receptores de pirimidin-ciclohexil-glucocorticoides.
CY1110828T1 (el) Τροποποιημενοι πυριμιδινικοι ρυθμιστες του γλυκοκορτικοειδους υποδοχεα
WO2021195782A8 (en) Methods of using myt1 inhibitors
MX2023007403A (es) Método de preparación de los moduladores del receptor de ciclohexilo de pirimidina glucocorticoides.
CL2019001107A1 (es) Receptor quimérico de citocinas. (divisional solicitud 201800415).
MY161170A (en) Pyrimidine cyclohexyl glucocorticoid receptor modulators
WO2024039901A3 (en) Cdk2 degraders and uses thereof
JOP20200177A1 (ar) طرق علاج السرطان باستخدام الأجسام المضادة anti-pd-1 المناهضة
ATE485824T1 (de) Polycyclische pyrimidine als kaliumionenkanal- modulatoren
PH12023500023A1 (en) Cdk2 degraders and uses thereof
ATE518010T1 (de) Aktive oberflächengekoppelte polymerasen
MX2020012831A (es) Moduladores del receptor de glucocorticoide de pirimidina ciclohexenilo.
PH12020551140A1 (en) Spiro-lactam nmda receptor modulators and uses thereof
PH12020551144A1 (en) Spiro-lactam nmda receptor modulators and uses thereof
ATE451914T1 (de) Dispergierbare bosertan-tablette
ZA202310057B (en) Anti-c-met antibody drug conjugates
MY205549A (en) Solid forms of an azolopyrimidine compound
MX2023002045A (es) Anticuerpos anti-pd-1 multiparatopicos y usos de los mismos.
WO2022032073A3 (en) Trpml modulators
MX2025005092A (es) Anticuerpo anti-trem2 y usos del mismo
MX2024014832A (es) Métodos para preparar moduladores del receptor de glucocorticoides de azadecalina fusionados con heteroaril-cetona
WO2021226439A8 (en) Engineered relaxins and methods of use thereof
MX2025006221A (es) Anticuerpos anti-tfr1 y usos de los mismos
MX2023014984A (es) Anticuerpos anti-csp.